Patents by Inventor Keith E. DROUET

Keith E. DROUET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11603345
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: March 14, 2023
    Assignee: Epizon Pharma, Inc.
    Inventors: Keith E. Drouet, James A. Tumlin, John M. Rudey
  • Publication number: 20220348530
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
    Type: Application
    Filed: May 12, 2022
    Publication date: November 3, 2022
    Applicant: Epizon Pharma, Inc.
    Inventors: Keith E. Drouet, James A. Tumlin, John M. Rudey
  • Patent number: 11332427
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: May 17, 2022
    Assignee: Epizon Pharma, Inc.
    Inventors: Keith E. Drouet, James A. Tumlin, John M. Rudey
  • Publication number: 20210009494
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 14, 2021
    Applicant: Epizon Pharma, Inc.
    Inventors: Keith E. Drouet, James A. Tumlin, John M. Rudey
  • Patent number: 10822295
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use. Also disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of a menaquinol compound as disclosed above, or a mixture thereof, and a pharmaceutically acceptable excipient, wherein the composition is effective for the treatment of a condition associated with vitamin K selected from for the treatment of osteoporosis and arteriosclerosis.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: November 3, 2020
    Assignee: EPIZON PHARMA, INC.
    Inventors: Keith E. Drouet, James A. Tumlin
  • Publication number: 20200079718
    Abstract: The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 12, 2020
    Applicant: Epizon Pharma, Inc.
    Inventors: Keith E. Drouet, James A. Tumlin
  • Publication number: 20160031800
    Abstract: Provided are methods for the synthesis of compounds including chiral kynurenine compounds, intermediates useful for the synthesis thereof, and related compounds. For example, methods are provided for the synthesis of L-4-chlorokynurenine.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Inventors: Alexander TRETYAKOV, Keith E. DROUET, William SANDERS